EP3784663
Setin 4-amínóísóindólín-1,3-díón-efnasambönd og notkun þeirra við meðhöndlun á eitilæxli
:
EP einkaleyfi í gildi á Íslandi:
22.4.2019:
12.7.2023:
19726225.6
:
3.10.2023:
15.11.2023
:
21.4.2039:
21.4.2026:
30.4.2026
:
SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND THEIR USE FOR TREATING LYMPHOMA
22.4.2019
12.7.2023
3.10.2023
15.11.2023
21.4.2026
:
Celgene Corporation:
86 Morris Avenue, Summit, NJ 07901, US
:
ALEXANDER, Matthew, D.:
San Diego, CA 92121, US
:
CARRANCIO, Soraya:
San Diego, CA 92121, US
:
CORREA, Matthew, D.:
San Diego, CA 92121, US
:
GRANT, Virginia Heather, Sharron:
San Diego, CA 92121, US
:
HANSEN, Joshua:
San Diego, CA 92121, US
:
HARRIS, Roy, L.:
San Diego, CA 92121, US
:
HUANG, Dehua:
San Diego, CA 92121, US
:
KERCHER, Timothy, S.:
San Diego, CA 92121, US
:
LOPEZ-GIRONA, Antonia:
San Diego, CA 92121, US
:
NAGY, Mark, A.:
San Diego, CA 92121, US
:
PLANTEVIN-KRENITSKY, Veronique:
San Diego, CA 92121, US
:
G.H. Sigurgeirsson ehf.:
Borgartúni 26, 105, Reykjavík,
:
201862661525 P:
23.4.2018:
US
:
US2019028471:
22.4.2019
:
C07D 401/14, C07D 491/08, C07D 401/04, C07D 417/14, C07D 491/10, A61P 35/00, A61K 31/454
: 6
: 7.3.2024
: 21.4.2025
: Árnason Faktor ehf.
: 7
: 18.3.2025
: 21.4.2026
: Árnason Faktor ehf.